{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:59:18Z","timestamp":1789192758021,"version":"build-2803163510"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Paroxysmal nocturnal haemoglobinuria (<jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>) is a rare, acquired, clonal haemopoietic stem cell disorder that causes chronic intravascular haemolysis, increases the risk of thrombosis and results in significant patient morbidity and mortality. The symptoms of <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content> may have a major impact on patient quality of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To assess patient fatigue and health\u2010related quality of life in 29 patients with <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content> using the <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>unctional <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>ssessment of <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>hronic <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>llness <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>herapy <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>atigue subscale version 4 (<jats:styled-content style=\"fixed-case\">FACIT<\/jats:styled-content>\u2010Fatigue) and the <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>uropean <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>rganization for <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>esearch and <jats:styled-content style=\"fixed-case\">T<\/jats:styled-content>reatment of <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ancer <jats:styled-content style=\"fixed-case\">Q<\/jats:styled-content>uality\u2010of\u2010<jats:styled-content style=\"fixed-case\">L<\/jats:styled-content>ife <jats:styled-content style=\"fixed-case\">Q<\/jats:styled-content>uestionnaire\u2010C30, version 3 (<jats:styled-content style=\"fixed-case\">EORTC QLQ<\/jats:styled-content>\u2010C30).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Following completion of the questionnaires, patients were interviewed to assess the validity, clarity, relevance and comprehensiveness of the assessments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, patients considered both the <jats:styled-content style=\"fixed-case\">FACIT<\/jats:styled-content>\u2010Fatigue and <jats:styled-content style=\"fixed-case\">EORTC QLQ<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>30 instruments to be relevant and adequate in assessing the level of <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>\u2010associated fatigue and other quality\u2010of\u2010life measures. The <jats:styled-content style=\"fixed-case\">FACIT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>atigue questionnaire was considered to be clear and to comprehensively cover <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>\u2010related fatigue. The <jats:styled-content style=\"fixed-case\">EORTC QLQ<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>30 instrument was considered to be easy to understand, but of an overall lower relevance, although some differences between countries were observed. Patients suggested additional questions that could be incorporated into future <jats:styled-content style=\"fixed-case\">EORTC QLQ<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>30 versions to make it more relevant to <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study confirms the validity of the <jats:styled-content style=\"fixed-case\">FACIT<\/jats:styled-content>\u2010Fatigue and the <jats:styled-content style=\"fixed-case\">EORTC QLQ<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>30 questionnaires in this patient population and their routine use should be considered in the management of patients with <jats:styled-content style=\"fixed-case\">PNH<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1445-5994.2012.02924.x","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T10:51:08Z","timestamp":1345632668000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cross\u2010sectional validation study of patient\u2010reported outcomes in patients with paroxysmal nocturnal haemoglobinuria"],"prefix":"10.1111","volume":"43","author":[{"given":"I.","family":"Weitz","sequence":"first","affiliation":[{"name":"Keck\u2010USC School of Medicine  Los Angeles California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Meyers","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University  Portland Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lamy","sequence":"additional","affiliation":[{"name":"Pontchaillou Hospital  Rennes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.\u2010Y.","family":"Cahn","sequence":"additional","affiliation":[{"name":"Centre Hospitalo\u2010Universitaire  Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Uranga","sequence":"additional","affiliation":[{"name":"Hospital Donostia  San Sebastian"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Garc\u00eda Vela","sequence":"additional","affiliation":[{"name":"University Hospital Getafe  Madrid"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Sanz","sequence":"additional","affiliation":[{"name":"University Hospital La Fe  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Severino","sequence":"additional","affiliation":[{"name":"Alexion Pharmaceuticals, Inc.  Cheshire Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals  Leeds UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hillmen","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals  Leeds UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hill","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals  Leeds UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"985","article-title":"The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire","volume":"108","author":"Hill A","year":"2006","journal-title":"ASH Annu Meet Abstr"},{"key":"e_1_2_7_3_1","first-page":"1095","article-title":"Screening for inherited thrombophilia: indications and therapeutic implications","volume":"87","author":"DeStefano V","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095646"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21757"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.13.1653"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511093331904"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000126763.68170.46"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)12360-1"},{"key":"e_1_2_7_10_1","first-page":"205","article-title":"High prevalence and mortality associated with thromboembolism in Asian patients with paroxysmal nocturnal hemglobinuria (PNH)","volume":"95","author":"Lee J","year":"2010","journal-title":"Haematologica"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06554.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-04-1717"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08096.x"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880010601185892"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.016121"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.04.001"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.03.025"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.07029"},{"key":"e_1_2_7_19_1","first-page":"422","article-title":"Evaluation of paroxysmal nocturnal hemoglobinuria disease burden in patients enrolled in the international PNH registry","volume":"95","author":"Urbano\u2010Ispizua A","year":"2010","journal-title":"Haematologica"},{"key":"e_1_2_7_20_1","first-page":"4241","article-title":"Association between elevated hemolysis at diagnosis and early mortality and risk of thrombosis In paroxysmal nocturnal hemoglobinuria (PNH) patients with cytopenia","volume":"116","author":"Kim JS","year":"2010","journal-title":"ASH Annu Meet Abstr"},{"key":"e_1_2_7_21_1","first-page":"271","article-title":"Renal impairment ia a risk factor for early mortality in patients with paroxysmal nocturnal hemoglobinuria (PNH)","volume":"96","author":"Kim JS","year":"2011","journal-title":"Hematologica"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031688"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061648"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-094136"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-333997"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00274-6"},{"key":"e_1_2_7_27_1","volume-title":"The FACIT\u2010Fatigue Scale: Description, Reliability and Validity.","author":"Cella D","year":"2003"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.5.1249"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00296-0"},{"key":"e_1_2_7_31_1","first-page":"125","article-title":"The effects of anemia and anemia treatment on the quality of life of people with cancer","volume":"16","author":"Cella D","year":"2002","journal-title":"Oncology"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-133918"},{"key":"e_1_2_7_33_1","first-page":"419","volume-title":"Hematology: Basic Principles and Practice","author":"Brodsky RA","year":"2005"},{"key":"e_1_2_7_34_1","first-page":"486","article-title":"Eculizumab reduces pulmonary hypertension through inhibition of hemolysis\u2010associated nitric oxide consumption in patients with paroxysmal nocturnal hemoglobinuria","volume":"112","author":"Hill A","year":"2008","journal-title":"ASH Annu Meet Abstr"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0009"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0871-3"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04992.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(03)00264-7"},{"issue":"1","key":"e_1_2_7_39_1","first-page":"S57","article-title":"Stem cell transplantation for paroxysmal nocturnal haemoglobinuria: an on going joint study of the AAWP EBMT Group and the French Society of Haematology","volume":"43","author":"Latour RP","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.017269"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0564"},{"key":"e_1_2_7_42_1","first-page":"40","article-title":"Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria","volume":"90","author":"Hill A","year":"2005","journal-title":"Haematologica"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.04.005"},{"key":"e_1_2_7_44_1","first-page":"135","article-title":"Assessment of quality of life in lymphedema patients: validity and reliability of the Swedish version of the Lymphedema Quality of Life Inventory (LQOLI)","volume":"43","author":"Klern\u00e4s P","year":"2010","journal-title":"Lymphology"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-011-0616-y"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2012.02924.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2012.02924.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:03:57Z","timestamp":1697328237000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2012.02924.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/j.1445-5994.2012.02924.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02924.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]},"assertion":[{"value":"2012-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-07-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}